The utility of 1,2 cyclohexanedione-modified low density lipoprotein (CHD-LDL) as a marker for the measurement of receptor independent LDL catabolism has been assessed by examining its metabolic properties in cultured human fibroblasts and in rabbits. Cell culture studies showed that the inhibition of high affinity membrane receptor binding produced by the modification could be partially revers...

We previously demonstrated reduced levels of low density lipoprotein (LDL) cholesterol in association with increased total fractional catabolic rates (FCR( of LDL apoprotein B (apo B) in individuals with myeloproliferative diseases (MPD). The removal of LDL from plasma and interstitial fluid is mediated via receptor and nonreceptor pathways. We attempted to quantitate LDL catabolism via each of...

Lipoprotein cholesterol (C) supports the high rate of progesterone production by the human placenta as endogenous cholesterol synthesis is low. To study underlying mechanisms whereby lipoproteins, including high density lipoprotein-2 (HDL2), stimulate progesterone secretion, trophoblast cells were isolated from human term placentas and maintained in primary tissue culture. Lipoproteins were add...

Cysteine (Cys) is prone to diverse post-translational modifications in proteins, including oxidation into sulfenic acid (Cys-SOH) by reactive oxygen species generated under oxidative stress. Detection of low concentrated and metastable Cys-SOH within complex biological matrices challenging due the dynamic concentration range proteins samples. Herein, visible laser-induced dissociation (LID) imp...

A green and efficient protocol for the synthesis of 3,3,6,6-tetramethyl-9-aryl-1,8-dioxooctahydroxanthene derivatives via cyclocondensation of 5,5-dimethyl-1,3-cyclohexanedione and aromatic aldehydes in the presence of catalytic amount of 10-molybdo-2-vanadophosphoric acid under solvent-free conditions has been described. The 10-molybdo-2-vanadophosphoric acid was prepared and characterized by ...